| 注册
首页|期刊导航|山东医药|“一站式”复合技术(Hybrid)在冠心病中的应用研究

“一站式”复合技术(Hybrid)在冠心病中的应用研究

刘晓明 刘季春 周学亮 喻本桐 吴起才 万力

山东医药2012,Vol.52Issue(33):41-43,3.
山东医药2012,Vol.52Issue(33):41-43,3.

“一站式”复合技术(Hybrid)在冠心病中的应用研究

“One-stop” composite technology ( Hybrid) application in coronary heart disease research

刘晓明 1刘季春 1周学亮 1喻本桐 1吴起才 1万力1

作者信息

  • 1. 南昌大学第一附属医院,南昌333000
  • 折叠

摘要

Abstract

Objective To evaluate the feasibility, safety, and clinical outcomes of the hybnd coronary artery bypass grafting surgery in 8 patients. Methods Hybrid coronary artery bypass grafting surgery was performed in 8 patients, combined with hypertension in 6 eases, diabetes mellitus in 4 cases, remote myocardial infarction in 5 cases, renal insufficiency in 2 cases, and cardiac insufficiency in 3 cases. Preoperative coronary angiography prompted the stenosis of left, anterior descending artery (LAD) was 75% ~ 100% , accompanied by 70%~98% stenosis of RCA or left circumflex artery. Cardiac ultrasonography tip of left ventricular ejection fraction was 0.41 to 0. 62(0. 55 ±0. 16). Results There was no death, hemorrhage, stroke, arrhythmias, myocardial infarction, postoperative wound infection and other complications in this group. Beating heart coronary artery bypass grafting surgery time was 1. 6 to 2.7 (1.7 ± 0. 9) h. The Endotracheal intubation time was 5 - 13(7. 8 ±2.9) h. The 24 h pleural effusion was 65 -410(213.4 ±89.3) mL. The ICU stay time was 1 ~ 2 d( 1.4 ±0. 5 ) d. The postoperative hospital stay was 5 -9(5.7±1. 9 ) d. Follow-up duration was 0.7~2.7 years, there was. no long-term myocardial infarction and death, and no re-operation. Conclusion "One-stop" composite technology ( Hybrid) in treatment of multivessel coronary artery disease is a safe, effective surgical approach, its long-term efficacy remains to be verified by more clinical applications and clinical trials.

关键词

心肌缺血/hybrid技术/外科手术

Key words

myocardial ischemia/ Hybrid/ surgical procedures, operative

分类

医药卫生

引用本文复制引用

刘晓明,刘季春,周学亮,喻本桐,吴起才,万力..“一站式”复合技术(Hybrid)在冠心病中的应用研究[J].山东医药,2012,52(33):41-43,3.

基金项目

江西省科技厅资助项目(2009BSB11207). (2009BSB11207)

山东医药

OACSTPCD

1002-266X

访问量0
|
下载量0
段落导航相关论文